Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging.

In conclusion, the scFv-hERG1-Cys possesses features which make it a suitable tool for application in cancer molecular imaging. PMID: 30405887 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/30405887?dopt=Abstract

Source: Oncotarget - November 9, 2018 Category: Cancer & Oncology Tags: Oncotarget Source Type: research